Published in
Elsevier, European Journal of Cancer, (115), p. 4-12, 2019
DOI: 10.1016/j.ejca.2019.03.022
Links
Tools
Clinical outcomes and prognostic factors in recurrent and/or metastatic head and neck cancer patients treated with chemotherapy plus cetuximab as first-line therapy in a real-world setting
Journal article published in 2019 by
Roberta Depenni,
Maria Cossu Rocca,
Daris Ferrari,
Giuseppe Azzarello,
Cinzia Baldessari,
Massimiliano Alù,
Franco Nolé,
Carla Codecà,
Giorgia Boscolo,
Marco Piccininni 
,
Stefano Cavalieri ,
Paolo Bossi
,
Stefano Cavalieri ,
Paolo Bossi
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 